AQSZF (Aequus Pharmaceuticals) Ending Cash Position : $0.02 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Ending Cash Position?

Aequus Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 was $0.02 Mil.

Aequus Pharmaceuticals's quarterly Ending Cash Position declined from Mar. 2024 ($0.18 Mil) to Jun. 2024 ($0.03 Mil) and declined from Jun. 2024 ($0.03 Mil) to Sep. 2024 ($0.02 Mil).

Aequus Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 ($1.87 Mil) to Dec. 2022 ($0.18 Mil) and declined from Dec. 2022 ($0.18 Mil) to Dec. 2023 ($0.13 Mil).

Aequus Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Aequus Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Ending Cash Position Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.37

1.34

1.87

0.18

0.13

Aequus Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															0.08	0.13	0.18	0.03	0.02

Aequus Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aequus Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.187	+	-0.06
	=	0.13

Aequus Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.032	+	-0.014
	=	0.02

Aequus Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.